Filter by Event: ECCMID 2023
Impact of the COVID Pandemic in Susceptibility Patterns of Gram- Negative Organisms: A Report from the SENTRY Antimicrobial Surveillance Program
Impact of the COVID Pandemic in Susceptibility Patterns of Gram-Negative Organisms: A Report from the SENTRY Antimicrobial Surveillance Program. Lead author: Mariana Castanheira. Presented at ECCMID 2023, April 15-18, Copenhagen.
Frequency of Occurrence and Antimicrobial Susceptibility of Bacteria Isolated from Patients Hospitalised with Pneumonia in Europe and United States: Results from the SENTRY Program (2019–2021)
Frequency of Occurrence and Antimicrobial Susceptibility of Bacteria Isolated from Patients Hospitalised with Pneumonia in Europe and United States: Results from the SENTRY Program (2019–2021). Lead author: Helio Sader. ECCMID 2023, April 15-18, Copenhagen.
In Vitro Activity of Omadacycline and Comparator Agents Against 485 Infrequently Encountered Bacterial Pathogens from the SENTRY Surveillance Programme
In Vitro Activity of Omadacycline and Comparator Agents Against 485 Infrequently Encountered Bacterial Pathogens from the SENTRY Surveillance Programme. Lead author: Michael Huband. ECCMID 2023, April 15-18, Copenhagen.
In Vitro Activity of SPR206 and Comparator Compounds against Enterobacterales Isolates Responsible for Infections in Hospitals in Europe and Adjacent Regions
In Vitro Activity of SPR206 and Comparator Compounds against Enterobacterales Isolates Responsible for Infections in Hospitals in Europe and Adjacent Regions. Lead Author: Rodrigo Mendes, ECCMID 2023, April 15-18, Copenhagen.
Cefiderocol In Vitro Activity Against Molecularly Characterized Acinetobacter baumannii-calcoaceticus complex and Pseudomonas aeruginosa Clinical Isolates Causing Infection in Europe and Adjacent Regions (2020–2021)
Cefiderocol In Vitro Activity Against Molecularly Characterized Acinetobacter baumannii-calcoaceticus complex and Pseudomonas aeruginosa Clinical Isolates Causing Infection in Europe and Adjacent Regions (2020–2021). Lead author: Rodrigo Mendes. ECCMID 2023, April 15-18, Copenhagen.
Comparison of In Vitro Activity of Cefiderocol and Comparator Agents Against Molecularly Characterized Carbapenem-resistant Enterobacterales Clinical Isolates Causing Infections in Europe and Surrounding Regions (2020–2021)
Comparison of In Vitro Activity of Cefiderocol and Comparator Agents Against Molecularly Characterized Carbapenem-resistant Enterobacterales Clinical Isolates Causing Infections in Europe and Surrounding Regions (2020–2021). Lead author: Dee Shortridge, ECCMID 23, April 15-18, Copenhagen.
In Vitro Activity of Manogepix and Comparators against 610 Infrequently Encountered Yeast and Mould Isolates from the SENTRY Surveillance Program (2017–2022)
In Vitro Activity of Manogepix and Comparators against 610 Infrequently Encountered Yeast and Mould Isolates from the SENTRY Surveillance Program (2017–2022). Lead author: Michael Huband, ECCMID 2023, April 15-18, Copenhagen.
Activity of SPR206 and Comparator Agents Against Pseudomonas aeruginosa and Acinetobacter spp. Causing Infections in Europe and Adjacent Regions
Activity of SPR206 and Comparator Agents Against Pseudomonas aeruginosa and Acinetobacter spp. Causing Infections in Europe and Adjacent Regions. Lead author: Rodrigo Mendes, ECCMID 2023, April 15-18, Copenhagen.
Activity of Cefiderocol and Comparator Agents against US Isolates of Pseudomonas aeruginosa, Acinetobacter baumannii-calcoaceticus species complex, and Stenotrophomonas maltophilia, Including Carbapenem-Resistant Isolates from the SENTRY Antimicrobial Surveillance Program (2020–2022)
Activity of Cefiderocol and Comparator Agents against US Isolates of Pseudomonas aeruginosa, Acinetobacter baumannii-calcoaceticus species complex, and Stenotrophomonas maltophilia, Including Carbapenem-Resistant Isolates from the SENTRY Antimicrobial Surveillance Program (2020–2022)
Rezafungin Activity against Candida and Aspergillus Isolates Causing Invasive Infections in European Medical Centres (2019–2021)
Rezafungin Activity against Candida and Aspergillus Isolates Causing Invasive Infections in European Medical Centres (2019–2021). Lead author: Cecilia Carvalhaes. ECCMID 2023, April 15-18, 2023, Copenhagen.
Antimicrobial Activity of Aztreonam-Avibactam against Gram-negative Bacteria Isolated from Patients Hospitalised with Pneumonia in European Medical Centres (2020–2021)
Antimicrobial Activity of Aztreonam-Avibactam against Gram-negative Bacteria Isolated from Patients Hospitalised with Pneumonia in European Medical Centres (2020–2021). Lead author: Helio Sader, ECCMID 2023, April 15-18, Copenhagen.
In vitro Activity of Novel Compound RG6006 Against Clinical Isolates of Acinetobacter baumannii-calcoaceticus complex in the Presence of 20% Human Serum
In vitro Activity of Novel Compound RG6006 Against Clinical Isolates of Acinetobacter baumannii-calcoaceticus complex in the Presence of 20% Human Serum. Lead author: Dee Shortridge. Presented at ECCMID 2023, April 15-18, 2023, Copenhagen.
In vitro activity of gepotidacin against Escherichia coli causing urinary tract infections between 2019–2021 in Europe, Russia, Israel, and Turkey, including molecularly characterized fluoroquinolone-resistant subsets
In vitro activity of gepotidacin against Escherichia coli causing urinary tract infections between 2019–2021 in Europe, Russia, Israel, and Turkey, including molecularly characterized fluoroquinolone-resistant subsets. Lead author: Rodrigo Mendes, ECCMID 2023, April 15-18, Copenhagen.
In Vitro Activity of Bacteriophage Cocktail Tested Against Pseudomonas aeruginosa Cystic Fibrosis Isolates
In Vitro Activity of Bacteriophage Cocktail Tested Against Pseudomonas aeruginosa Cystic Fibrosis Isolates. Lead author: Timothy Doyle. ECCMID, April 15-18, Copenhagen.
VITEK2 Advanced Expert System β-Lactam Resistance Phenotyping Compared to Whole Genome Sequencing in Enterobacterales Isolates from European Medical Centres
VITEK2 Advanced Expert System β-Lactam Resistance Phenotyping Compared to Whole Genome Sequencing in Enterobacterales Isolates from European Medical Centres. Lead author: Cecilia Carvalhaes. Presented at ECCMID 2023, April 15-18, Copenhagen.
Aztreonam-Avibactam Activity against Gram-negative Bacteria Isolated from Patients with Bloodstream Infections from Europe, Asia, and Latin America (2020–2021)
Aztreonam-Avibactam Activity against Gram-negative Bacteria Isolated from Patients with Bloodstream Infections from Europe, Asia, and Latin America (2020–2021). Lead author: Helio Sader, ECCMID 2023, April 15-18, Copenhagen.
Trends on the Activity of Mould-active Agents Against Aspergillus fumigatus Clinical Isolates With and Without Cyp51 Alterations from Europe and North America (2017–2021)
Trends on the Activity of Mould-active Agents Against Aspergillus fumigatus Clinical Isolates With and Without Cyp51 Alterations
from Europe and North America (2017–2021). Lead author: Cecilia Carvalhaes. Presented at ECCMID 23, April 15-18, Copenhagen.
Activity of Cefiderocol and Comparator Agents against European Enterobacterales, Including Carbapenem-Resistant Isolates, From the SENTRY Antimicrobial Surveillance Program (2020–2022)
Activity of Cefiderocol and Comparator Agents against European Enterobacterales, Including Carbapenem-Resistant Isolates, From the SENTRY Antimicrobial Surveillance Program (2020–2022). Lead author: Dee Shortridge, ECCMID, April 15-18, Copenhagen.
Rezafungin Activity against Candidemia isolates collected from European medical centres (2019–2021)
Rezafungin Activity against Candidemia isolates collected from European medical centres (2019–2021). Lead author: Cecilia Carvalhaes. Presented at ECCMID 2023, April 15-18, 2023, Copenhagen.
Enterobacter hormaechei Carrying blaNDM Predominates Among Carbapenem-resistant Enterobacter spp. Collected During the SENTRY Antimicrobial Surveillance Program (2016–2021)
Enterobacter hormaechei Carrying blaNDM Predominates Among Carbapenem-resistant Enterobacter spp. Collected During the SENTRY Antimicrobial Surveillance Program (2016–2021). Lead author: Hank Kimbrough.
Bloodstream Infections in Europe and United States: Aetiology and Antimicrobial Susceptibility Results from the SENTRY Antimicrobial Surveillance Program (2019–2021)
Bloodstream Infections in Europe and United States: Aetiology and Antimicrobial Susceptibility Results from the SENTRY Antimicrobial Surveillance Program (2019–2021). Lead author: Helio Sader. Presented at ECCMID 2023, April 15-18, Copenhagen.
Comparison of Cefiderocol and Cefepime-Taniborbactam Activities against Resistant Subgroups of Enterobacterales and Pseudomonas aeruginosa, and Cefiderocol and Sulbactam-Durlobactam Against Carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex
Comparison of Cefiderocol and Cefepime-Taniborbactam Activities against Resistant Subgroups of Enterobacterales and Pseudomonas aeruginosa, and Cefiderocol and Sulbactam-Durlobactam Against Carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex. Lead Author: Dee Shortridge, ECCMID 2023, April 15-18, Copenhagen.
Activity of Cefiderocol and Comparator Agents against US Enterobacterales, Including Carbapenem-Resistant Isolates, from the SENTRY Antimicrobial Surveillance Program (2020–2022)
Activity of Cefiderocol and Comparator Agents against US Enterobacterales, Including Carbapenem-Resistant Isolates, from the SENTRY Antimicrobial Surveillance Program (2020–2022). Lead author: Dee Shortridge, ECCMID, April 15-18, Copenhagen.
Recent Increase in Fluconazole-Nonsusceptible Candida parapsilosis in a Global Surveillance with the Expansion of the Erg11 Y132F genotype and a Rapid Detection Method to Detect This Alteration
Recent Increase in Fluconazole-Nonsusceptible Candida parapsilosis in a Global Surveillance with the Expansion of the Erg11 Y132F genotype and a Rapid Detection Method to Detect This Alteration. Lead Author: Mariana Castanheira, ECCMID 2023, April 15-18, Copenhagen.
